1.
Formulation and optimization of liquisolid tablet for improving the dissolution profile of rivaroxaban by using DoE approachand antithrombic activity. JOC [Internet]. 2025 Oct. 10 [cited 2025 Dec. 17];24(3s):812-30. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1715